All Posts:melanoma
-
Celebrating ‘Thrivership’
Survivors of melanoma and kidney cancer gathered to celebrate “thrivership” during a luncheon that might not have been possible as recently as 10 years ago as people with these types of cancer are living longer and experiencing cures.
Category: Lombardi Stories
-
Key Studies Conducted at Georgetown Lombardi Lead to Better Treatment for People With Melanoma
(March 1, 2023) — Results from a pair of clinical trials published in recent months have changed the treatment landscape for people with advanced melanoma, offering a clearer path for improved survival. The studies, conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and other cancer centers around the country, explored the best treatment options and […]
Category: Lombardi Stories
-
Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy
The findings, coupled with results from another recent clinical trial, mark significant advances in the treatment of melanoma. WASHINGTON (September 27, 2022) — A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received […]
Category: News Release
-
Trial Stopped Early: Giving Immunotherapy Before Targeted Rx Improves Survival in Advanced Melanoma
WASHINGTON (November 15, 2021) — More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment with targeted therapies. The finding comes from a clinical trial that was stopped early […]
Category: News Release
-
Indoor Tanning May Be an Addiction Abetted by Both Genetic and Psychiatric Factors
A new study reported by researchers at Georgetown Lombardi sheds light on factors that may influence an addiction to indoor tanning in a subset of women.
Category: News Release
-
Melanoma Survivors Luncheon Celebrates Cancer Research Achievement
(May 10, 2016) — If advances in cancer treatment dramatically change the outcome for individual patients, imagine its impact on a physician who has only recently been able to deliver good news. “I know I speak for my colleagues in saying that I have been waiting my whole career for a day like today.” That’s […]
Category: Lombardi Stories
-
A Cancer Survivors’ Luncheon Like No Other
(April 30, 2016) — Last year, Stanley Sher, a lawyer who lives in D.C., was certain his time was ending. “I had reached a very low, low point — three surgeries, radiation treatment and nothing had worked,” he said. “I was several months away from disappearing.” Leta Brown had a similar experience when, at age […]
Category: Lombardi Stories
-
New Clinical Trial Led by Lombardi Doctor to Compare Drug Sequences in Treatment of Melanoma
August 31, 2015 — A new nationwide clinical trial that recently opened at Georgetown Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital will help doctors determine not only which drugs are most effective, but also how the order in which the drugs are administered affects patient outcomes. Conducted by the ECOG-ACRIN Cancer Research Group, […]
Category: Lombardi Stories